Yasser A. Aldhamen - Concepedia

Author

Yasser A. Aldhamen

Also Known As

Aldhamen, Y.A., Shah, S., Y A Aldhamen, Yanmei Hu, Yasser A Aldhamen, Yasser A. Aldhamen, Yasser Aldhamen, Yasser Ali Aldhamen

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Michigan State University Michigan United Duke Medical Center Western University of Health Sciences National and Kapodistrian University of Athens

About

Yasser A. Aldhamen is an author at Michigan State University specializing in medicine, immunology, and innate immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	296
2	Immunology	12	13	296
3	Cell Biology	8	8	166
4	Allergy	6	6	134
5	Hepatology	1	1	24

Yasser A. Aldhamen

Publications

998

Citations

H-Index

Page 1

	Year	Citations
Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses Efthalia Zervoudi, Emmanuel Saridakis, James R. Birtley, Proceedings of the National Academy of Sciences	2013	125
SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment Patrick M. O’Connell, Sean Hyslop, Maja K. Blake, The Journal of Immunology	2020	101
Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing Efficacy Sergey S. Seregin, Daniel M. Appledorn, Aaron J. McBride, Molecular Therapy	2009	93
HIV-infected cannabis users have lower circulating CD16+ monocytes and IFN-γ-inducible protein 10 levels compared with nonusing HIV patients Michael D. Rizzo, Robert B. Crawford, Joseph E. Henriquez, AIDS	2017	77
Autoimmune Disease-Associated Variants of Extracellular Endoplasmic Reticulum Aminopeptidase 1 Induce Altered Innate Immune Responses by Human Immune Cells Yasser A. Aldhamen, Yuliya Pepelyayeva, David P. W. Rastall, Journal of Innate Immunity Erap1 Polymorphic VariantsInflammatory Lung DiseaseInnate Immune SystemImmunologyImmune Regulation	2015	46
Sublingual Administration of an Adenovirus Serotype 5 (Ad5)-Based Vaccine Confirms Toll-Like Receptor Agonist Activity in the Oral Cavity and Elicits Improved Mucosal and Systemic Cell-Mediated Responses against HIV Antigens despite Preexisting Ad5 Immunity Daniel M. Appledorn, Yasser A. Aldhamen, Sarah Godbehere, Clinical and Vaccine Immunology ImmunologyNk CellsCd4 T Cell ResponsesImmune SystemHuman Retrovirus	2010	44
SLAMF7 Is a Critical Negative Regulator of IFN-α–Mediated CXCL10 Production in Chronic HIV Infection Patrick M. O’Connell, Yuliya Pepelyayeva, Maja K. Blake, The Journal of Immunology	2018	42
Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector–triggered immune responses in vitro and in vivo Sergey S. Seregin, Yasser A. Aldhamen, Daniel M. Appledorn, Blood	2010	37
Endoplasmic Reticulum Aminopeptidase-1 Functions Regulate Key Aspects of the Innate Immune Response Yasser A. Aldhamen, Sergey S. Seregin, David P. W. Rastall, PLoS ONE	2013	34
A New Adenovirus Based Vaccine Vector Expressing an Eimeria tenella Derived TLR Agonist Improves Cellular Immune Responses to an Antigenic Target Daniel M. Appledorn, Yasser A. Aldhamen, William H. DePas, PLoS ONE	2010	34

Page 1